Browsing by Author Chong Jen Yu

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
15-Jul-2015Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapyTony Mok; Yi Long Wu; Jin Soo Lee; Chong Jen Yu; Virote Sriuranpong; Jennifer Sandoval-Tan; Guia Ladrera; Sumitra Thongprasert; Vichien Srimuninnimit; Meilin Liao; Yunzhong Zhu; Caicun Zhou; Fatima Fuerte; Benjamin Margono; Wei Wen; Julie Tsai; Matt Truman; Barbara Klughammer; David S. Shames; Lin Wu
1-Jun-2009Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinomaPiyorot Hongsachart; Rosa Huang-Liu; Supachok Sinchaikul; Fu Ming Pan; Suree Phutrakul; Yu Min Chuang; Chong Jen Yu; Shui Tein Chen
1-Jun-2011Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancerHsien Yu Tsai; Kongsak Boonyapranai; Supawadee Sriyam; Chong Jen Yu; Sz Wei Wu; Kay Hooi Khoo; Suree Phutrakul; Shui Tein Chen
1-Aug-2016Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancerTony Mok; Guia Ladrera; Vichien Srimuninnimit; Virote Sriuranpong; Chong Jen Yu; Sumitra Thongprasert; Jennifer Sandoval-Tan; Jin Soo Lee; Fatima Fuerte; David S. Shames; Barbara Klughammer; Matt Truman; Pablo Perez-Moreno; Yi Long Wu